Harpoon Medical, Inc., a clinical stage medical device company focused on the development and commercialization of transcatheter beating heart mitral valve repair technology, announced today that the company has hired Laura Brenton to serve as Vice President of Clinical Affairs.  Laura will lead Harpoon Medical's clinical program. She brings more than 25 years of clinical research experience with the last decade focused in the structural heart space to the Harpoon team.

"We are very happy to have Laura join our team to run the company's clinical program," said Bill Niland, CEO of Harpoon Medical.  "She joined Symetis in 2009 and was instrumental in securing multiple CE Mark approvals for the company's second generation TAVR device.  The knowledge and experience Laura gained during her time at Symetis, Boston Scientific and with numerous other medical device companies will be instrumental as she helps Harpoon transition from a clinical stage company to a commercial organization." 

Click here to read the rest of the story via PRNewswire